The burden of metabolic diseases amongst HIV positive patients on HAART attending the Johannesburg hospital

Current HIV Research

Volumn 9, Issue 4, 2011, Pages 247-252

  Julius, Henry ^a,b   Basu, Debashis ^a,b   Ricci, Elena ^c   Wing, Jeffrey ^a,d   Basu, Jayati Kusari ^a,d   Pocaterra, Daria ^c   Bonfanti, Paolo ^e  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^c UNIVERSITY OF MILAN   (Italy)

^d Chalotte Maxeke Johannesburg Academic Hospital   (South Africa)

^e A MANZONI HOSPITAL   (Italy)

Author keywords

Dyslipidemia; HAART; HIV; Hypertension; Prevalence; South Africa

Indexed keywords

ANTIRETROVIRUS AGENT; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; AGE; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CD4 LYMPHOCYTE COUNT; DIABETES MELLITUS; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERCHOLESTEROLEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; RISK FACTOR; SEX DIFFERENCE; SOUTH AFRICA;

EID: 79959951103     PISSN: 1570162X     EISSN: 18734251     Source Type: Journal    
DOI: 10.2174/157016211796320360     Document Type: Article

References (25)

1. UNAIDS. Report on the global AIDS epidemic. Chapter 2: Epidemic Update. www.unaids.org/documents/20101123_GlobalReport_Chap2_em.pdf (last access 12 April 2011).
2. Bradshaw D, Groenewald P, Laubscher R, Nannan N, Nojilana B, Norman R, Pieterse D, Schneider M. South African Medical Research Council. Initial burden of disease estimates for South Africa, 2000. www.mrc.ca.za/bod/initialbodestimates.pdf (last accessed nov 2010).
3. Carr A, Samaras K, Thorisdottir A. Diagnosis, prediction, and natural course of HIV-1 protease inhibitor associated lipodystrophy, hyperlipidaemia and diabetes mellitus: a cohort study. The Lancet 1999; 535(9170): 2093-2099.
4. Brown T, Cole S, Li X. Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the multicenter AIDS cohort study. Arch intern Med 2005; 165: 1179-1184.
5. Samaras K. Metabolic consequences and therapeutic options in highly active antiretroviral therapy in human immunodeficiency virus-1 infection. J Antimicrob Chemother 2008; 61: 238-245.
6. Bonfanti P, De Socio GVL, Marconi P, Franzetti M, Martinelli C, Vichi F, et al. Is metabolic syndrome associated to HIV infection per se? Results from the HERMES study. Curr HIV Res 2010; 8 (2): 165-171.
7. Mayosi BM, Flisher AJ, Laloo UG, Sitas F, Tollman SN, Bradshaw D. The burden of non-communicable diseases in South Africa. Lancet 2009; 374: 934-947.
8. World Health Organization. Obesity and overweight. www.who.int/mediacenter/factsheets/fs311/en/index.htm (last accessed november 2010).
9. Expert Panel on Detection, Evaluation and Treatment of high blood cholesterol in Adults. Executive summary of the Third Report of the National Cholesterol Educational Program (NCEP). JAMA 2001; 285: 2486-2497.
10. The IDF consensus worldwide definition of the Metabolic Syndrome. 2006. www.idf.org/webdata/doc/metS_def_update2006.pdf (last accessed November 2010).
11. SADHS. South Africa demographic and health survey (SADHS) 2003. Available online at www.search.gov.za/info/search.jsp (last accessed November 2010).
12. Steyn K, Gaziano TA, Bradshaw D, Laubscher R, Fourie J for the South African Demographic and Health Coordinating Team. Hypertension in South African adults: results from the Demographic and Health Survey, 1998. J Hypertens 2001; 19: 1717-1725
13. Barninghausen T, Welz T, Hosegood V, Batzing-Feigenbaum J, Tanser F, Herbst K, et al. Hiding in the shadows of the HIV epidemic: obesity and hypertension in a rural population with very high HIV prevalence in South Africa. J Hum Hypertens 2008; 22: 236-239.
14. Samaras K. Prevalence and pathogenesis of diabetes mellitus in HIV-1 infection treated with combined antiretroviral therapy. Journal of Acquir Immune Deficiency Syndrome 2009; 50(5): 499-505.
15. Jennings CL, Lambert EV, Collins M, Levitt NS, Goedecke JH. The atypical presentation of the metabolic syndrome components in black African women: the relationship with insulin resistance and the influence of regional adipose tissue distribution. Metabolism 2009; 58: 149-157.
16. Rosana N, Bradshaw D, Krisela S. Estimating the burden of disease attributable to high cholesterol in South Africa in 2000. S Afr Med J 2007; 97(8):708-715.
17. Lesi OA, Soyebi KS, Eboh CN. Fatty liver and hyperlipidemia in a cohort of HIV-positive Africans on highly active antiretroviral therapy. J Natl Med Assoc 2009; 101: 151-155.
18. George JA, Venter WDF, Van Deventer HE, Crowther NJ. A Longitudinal Study of the Changes in Body Fat and Metabolic Parameters in a South African Population of HIV-Positive Patients Receiving an Antiretroviral Therapeutic Regimen Containing Stavudine. AIDS Res Hum Retroviruses 2009; 25: 771-781.
19. Goedecke JH, Utzschneider K, Faulenbach MV, Rizzo M, Berneise K, Spinas GA, et al. Ethnic differences in serum lipoproteins and their determinants in South African women. Metabolism 2010; 59: 1241-1250.
20. Fourie CMT, Van Rooyen JM, Kruger A, Schutte AE. Lipid abnormalities in a never-treated HIV-1 subtype C-infection African population. Lipids 2010; 45: 73-80.
21. Garcìa-Calleja JM, Gouws E, Ghys PD. National population-based HIV prevalence surveys in sub-Saharan Africa: results and implication for HIV and AIDS estimates. Sex Trans Infect 2006; 82 S3: iii64-iii70.
22. Peltzer K, Mlambo G, Phaweni K. Factors determining prenatal HIV testing for prevention of mother to child transmission of HIV in Mpumalanga, South Africa. AIDS Behav 2010; 14: 1115-1123.
23. Bonfanti P, Ricci E, De Socio G, Zeme D, Carradori S, Penco G, et al. Metabolic Syndrome: a real threat for HIV-positive patients? Results from the SIMONE Study. J AIDS 2006; 42: 128-131.
24. Baekken M, Os I, Sandvik L, Oektedalen O. Hypertension in an urban HIV-positive population compared with the general population: influence of combination antiretroviral therapy. J Hypert 2008; 26: 2126-2133.
25. Buchacz K, Wiedle PJ, Moore D, Were W, Mermin J, Downing R, et al. Changes in Lipid Profile Over 24 Months Among Adults on First-Line Highly Active Antiretroviral Therapy in the Home- Based AIDS Care Program in Rural Uganda. J AIDS 2008; 47: 304-311.